WHATABURGER ANNOUNCES CEO RETIREMENT AND LEADERSHIP TRANSITION
With a distinguished career spanning two decades at Whataburger, Ed joined the company in 2004 as Controller. He was promoted to Chief Financial Officer in 2008, President in 2019, and CEO in 2020. Under Ed's leadership over the past five years, Whataburger has successfully expanded into 16 new states, opening more than 250 new stores.
"Ed's passion for the Whataburger brand has been unparalleled, and he has expertly guided the company to new heights, embodying the drive and resilience Texans are known for," stated
Reflecting on his time with Whataburger, Ed remarked, "Leading this company has truly been one of the greatest joys of my life. The incredible individuals and Family Members who make up our team are a blessing, and I am proud of what we have accomplished together."
In a seamless transition,
"Debbie has brought a wealth of knowledge and a strong vision for operational excellence and high-quality made-to-order food to Whataburger. We are excited for her to extend her energy and passion for building great teams and delivering extraordinary hospitality to customers across our expanding operations," added
"I am honored to be selected as the next CEO of Whataburger, a family-founded, beloved brand with a strong legacy and fan base," said
As Whataburger embarks on this new chapter, the spirit of
Debbie and her husband Bob reside in
Media Contact:
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/whataburger-announces-ceo-retirement-and-leadership-transition-302237262.html
SOURCE Whataburger
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NEXT PROPERTIES ANNOUNCES RESULTS OF EXCHANGE OFFERS FOR ANY & ALL OF ITS OUTSTANDING 6.950% SENIOR NOTES DUE 2044 AND 6.390% SENIOR NOTES DUE 2050 FOR ADDITIONAL 7.731% SENIOR SUSTAINABILITY-LINK
- STEPHEN A. SMITH ADDRESSES WHITE HOUSE DINNER ATTENDANCE, REAFFIRMS COMMITMENT TO HBCUs AND PROTECTING CORPORATE INVESTMENT IN BLACK EDUCATION
- Pathalys Pharma Presents Positive Data from Pivotal Phase 3 Studies of Upacicalcet in Featured Oral Presentation at ASN Kidney Week 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share